
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
Marketer
Medley Pharmaceuticals
Salt Composition
Voglibose (0.3mg) + Repaglinide (0.5mg) + Metformin (500mg)
Overview Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
Diabeta-Trio 0.3mg/0.5mg/500mg Extended-Release Tablets are a combined medication for managing type 2 diabetes. This treatment slows glucose absorption, boosts insulin production (the hormone regulating blood sugar), reduces liver glucose output, and enhances insulin responsiveness. Diabeta-Trio 0.3mg/0.5mg/500mg ER Tablets should be taken with meals, consistently at the same time daily for maximum effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose readings. Continue taking this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation without medical consultation can elevate blood sugar, risking kidney complications, vision loss, neuropathy, and limb damage. Remember, this medication is part of a comprehensive diabetes management plan including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include skin rash, altered taste, nausea, gas, diarrhea, stomach upset, and appetite loss. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart conditions before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor. Regular blood sugar monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogli-Rapid M 0.3mg/0.5mg/500mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR:
- Skin rash
- Taste change
- Nausea
- Flatulence
- Diarrhea
- Stomach pain
- Loss of appetite
- Hypoglycemia (low blood glucose level)
How to use Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vogli-Rapid M 0.3mg/0.5mg/500mg Extended-Release tablet should be administered with food.
How Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR works:
Vogli-Rapid M 0.3mg/0.5mg/500mg Extended-Release tablets contain voglibose, repaglinide, and metformin, three agents that manage blood sugar. Voglibose inhibits enzymes in the gut responsible for complex carbohydrate digestion, slowing glucose uptake. Repaglinide stimulates insulin secretion from the pancreas, particularly postprandially. This dual action prevents post-meal hyperglycemia. Metformin reduces hepatic glucose output, impedes intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Vogli-Rapid M 0.3mg/0.5mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Vogli-Rapid M 0.3mg/0.5mg/500mg sustained-release tablets in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Vogli-Rapid M 0.3mg/0.5mg/500mg SR tablets with breastfeeding are absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Vogli-Rapid M 0.3mg/0.5mg/500mg SR tablets. Dosage modification of Vogli-Rapid M 0.3mg/0.5mg/500mg SR tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR. Dosage modification of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR may be necessary; physician consultation is advised.
What if you forget to take Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR :
NA
Facts to Know About Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
